BPRN stock news
This page provides real-time market news, earnings updates, and company announcements related to Princeton Bancorp, Inc. (BPRN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-20 08:13 EST
Teledyne e2v Introduces Perciva 5D Camera: Occlusion-free 3D Vision for Industrial, Retail, and Robotic Imaging
Finviz2026-03-05 08:03:42
MISTRAS Group Issues Clarification Regarding Diluted EPS Excluding Special Items (Non-GAAP) Referenced During Q4 2025 Earnings Call
Finviz2026-03-05 17:42:07
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Finviz2026-03-06 13:04:13
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:15:50
Clearway Energy, Inc. Seeks Shareholder Approval at Annual Meeting to Simplify Public Share Class Structure
Finviz2026-03-09 21:09:10
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania
Finviz2026-03-10 12:03:10
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
Finviz2026-03-12 12:03:52
Canadian psychedelic drug manufacturer Optimi Health (OPTH.US) sets IPO price at $6-8 per share, aiming to raise $15 million
老虎证券2026-03-16 06:43:06
Space Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about March 20, 2026
Finviz2026-03-16 20:18:44
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Finviz2026-03-19 13:49:12
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behcet's Disease
Finviz2026-03-26 11:33:44
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
Finviz2026-03-30 11:03:47
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
Finviz2026-03-30 12:03:46
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Finviz2026-03-31 11:33:50
Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Finviz2026-04-02 11:33:07
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Finviz2026-04-07 10:54:52
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix Utilization
Finviz2026-04-07 12:33:48
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Finviz2026-04-08 10:57:43
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
Miami International Holdings Announces the Passing of Board Member Murray Stahl
Finviz2026-04-09 12:03:49
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Finviz2026-04-13 10:54:42
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Finviz2026-04-14 12:06:46
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
Finviz2026-04-14 12:06:48
Clearway Energy, Inc. Seeks Shareholder Approval at Annual Meeting to Simplify Public Share Class Structure
Finviz2026-03-09 21:09:10
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania
Finviz2026-03-10 12:03:10
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
Finviz2026-03-12 12:03:52
Canadian psychedelic drug manufacturer Optimi Health (OPTH.US) sets IPO price at $6-8 per share, aiming to raise $15 million
老虎证券2026-03-16 06:43:06
Space Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about March 20, 2026
Finviz2026-03-16 20:18:44
CytoSorbents Announces HotSwap Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Finviz2026-03-19 13:49:12
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behcet's Disease
Finviz2026-03-26 11:33:44
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
Finviz2026-03-30 11:03:47
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
Finviz2026-03-30 12:03:46
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Finviz2026-03-31 11:33:50
Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Finviz2026-04-02 11:33:07
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Finviz2026-04-07 10:54:52
Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix Utilization
Finviz2026-04-07 12:33:48
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Finviz2026-04-08 10:57:43
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
Miami International Holdings Announces the Passing of Board Member Murray Stahl
Finviz2026-04-09 12:03:49
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Finviz2026-04-13 10:54:42
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Finviz2026-04-14 12:06:46
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
Finviz2026-04-14 12:06:48
BPRN stock chart
BPRN stock detailsBPRN stock price change
On the last trading day, BPRN stock closed at 36.34 USD, with a price change of 2.98% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more